Drugs Made In America Acquisition DMII
NASDAQ DMII
$10.24 +0.00 (+0.00%)
At close: Nov 13, 2026 · 4:00 PM EST

Drugs Made In America Acquisition (DMII) Return on Capital Employed [ROCE] (2025 - 2026)

Updated

Drugs Made In America Acquisition's Return on Capital Employed [ROCE] was -0.12% in Q2 2026, down 0.01 percentage points from the prior quarter.

Analysis

Drugs Made In America Acquisition (DMII) Return on Capital Employed [ROCE] (2025 - 2026) Analysis & Trends

For FY2025, Return on Capital Employed [ROCE] at Drugs Made In America Acquisition came in at -0.19%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 BlackRock 189.07 Bn 145.60 Bn - -
2 Spdr Gold Trust 125.11 Bn -432.90 Bn - -
3 Brookfield 101.47 Bn -96.66 Bn - -
4 Blackstone 91.35 Bn 85.56 Bn - -
5 Kkr 87.89 Bn 54.59 Bn 1.76 Bn -
6 Brookfield Asset Management 82.34 Bn 77.22 Bn - -
7 Apollo Global Management 72.94 Bn 89.74 Bn 4.14 Bn -
8 Wheaton Precious Metals 59.70 Bn 59.70 Bn 538.50 Mn 23.42%
9 Ares Management 48.49 Bn 47.07 Bn 376.28 Mn -
10 Drugs Made In America Acquisition 652.29 Mn 651.45 Mn - -0.12%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.12%
Mar 31, 2026 -0.11%
Dec 31, 2025 -0.10%
API Access

Drugs Made In America Acquisition Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=DMII&period=max&api_key=YOUR_API_KEY